US 12,241,048 B2
Energy drinks and other nutritional aids derived from agave-based spirits
Robert W. Brocia, Bronxville, NY (US)
Assigned to Roar Holding LLC, New York, NY (US)
Filed by Roar Holding LLC, New York, NY (US)
Filed on Oct. 29, 2021, as Appl. No. 17/515,297.
Application 17/515,297 is a continuation of application No. 16/265,713, filed on Feb. 1, 2019, granted, now 11,160,774, issued on Nov. 2, 2021.
Application 16/265,713 is a continuation of application No. 14/856,438, filed on Sep. 16, 2015, granted, now 10,195,163, issued on Feb. 5, 2019.
Claims priority of provisional application 62/231,592, filed on Jul. 10, 2015.
Claims priority of provisional application 62/071,179, filed on Sep. 16, 2014.
Prior Publication US 2022/0047531 A1, Feb. 17, 2022
Int. Cl. C12Q 1/32 (2006.01); A23L 2/52 (2006.01); A23L 33/105 (2016.01); A61K 31/137 (2006.01); A61K 31/138 (2006.01); C12H 3/04 (2019.01); C12Q 1/26 (2006.01); G01N 33/14 (2006.01); G01N 33/569 (2006.01); A61K 36/00 (2006.01)
CPC C12H 3/04 (2019.02) [A23L 2/52 (2013.01); A23L 33/105 (2016.08); A61K 31/137 (2013.01); A61K 31/138 (2013.01); C12Q 1/26 (2013.01); C12Q 1/32 (2013.01); G01N 33/146 (2013.01); G01N 33/56972 (2013.01); A61K 36/00 (2013.01); G01N 2333/904 (2013.01); G01N 2333/90638 (2013.01); G01N 2500/02 (2013.01)] 7 Claims
OG exemplary drawing
 
1. A method for rating agave-derived beverages, comprising:
(a) assaying for monoamine oxidase (MAO) inhibitors in the presence of ethanol by adding MAO A and/or MAO B, alcohol dehydrogenase and nicotinamide adenine dinucleotide (NAD) to a sample of each of the beverages;
(b) assessing a level of inhibitory activity of the MAO inhibitors for each beverage based on results of the assaying; and
(c) assigning each beverage a position on a scale based on its level of inhibitory activity of the MAO inhibitors, wherein the MAO inhibitors are MAO A inhibitors or MAO B inhibitors or both, and wherein each assigned beverage comprises ethanol.